Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neuroblastoma × Irinotecan × Clear all

Phase

Phase 2 15 Phase 1 14 Phase 1/2 7 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 66 Colonic Neoplasms 28 Rectal Neoplasms 27 Neoplasm Metastasis 14 Stomach Neoplasms 10 Pancreatic Neoplasms 9 Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Esophageal Neoplasms 6 Small Cell Lung Carcinoma 5 Rhabdomyosarcoma 4 Intestinal Neoplasms 4 Gastrointestinal Neoplasms 4 Digestive System Neoplasms 4 Uterine Cervical Neoplasms 3 Sarcoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Cholangiocarcinoma 3 Rectal Diseases 2 Neoplasms by Histologic Type 2 Intestinal Diseases 2 Hepatoblastoma 2 Gastrointestinal Diseases 2 Digestive System Diseases 2 Colorectal Cancer Metastatic 2 Colorectal Adenocarcinoma 2 Colonic Diseases 2 Carcinoma 2 Adenocarcinoma Of Esophagus 2 Stage I Mixed Cell Type Kidney Wilms Tumor 1

Interventions

Cyclophosphamide 20 Carboplatin 16 Etoposide 14 Doxorubicin 13 Vincristine 12 Filgrastim 10 Cisplatin 10 Melphalan 9 Radiotherapy 8 Isotretinoin 7 Topotecan 6 Peripheral Blood Stem Cell Transplantation 6 Granulocyte Colony-Stimulating Factor 6 sargramostim 4 etoposide phosphate 4 dinutuximab 4 Neoadjuvant Therapy 4 Busulfan 4 Vindesine 3 Magnetic Resonance Spectroscopy 3 Ifosfamide 3 Colony-Stimulating Factors 3 Chemotherapy, Adjuvant 3 3-Iodobenzylguanidine 3 fluorodopa F 18 2 aldesleukin 2 Watchful Waiting 2 Thiotepa 2 Platinum 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07375563 2026-01-29

NB-NK-2026

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 3 Recruiting

Neuroblastoma, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡